<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03139188</url>
  </required_header>
  <id_info>
    <org_study_id>6789</org_study_id>
    <nct_id>NCT03139188</nct_id>
  </id_info>
  <brief_title>Palliative Care Unit Transfert Announcements</brief_title>
  <official_title>Palliative Care Transfer Announcements: Qualitative Analysis of the Perspective of Physicians and Their Patients With Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The course of care of a patient with a cancer whose evolution is pejorative, is marked by
      difficult announcements, called &quot;bad news&quot;. In the palliative phase, prognostic announcements
      are at the forefront. Of these, the announcement of a transfer to the Palliative Care Unit
      has not been the subject of any specific studies to the best of our knowledge. It therefore
      seemed interesting to us to explore the stakes of this particular announcement, a source of
      upheaval for the doctor and the patient, by gathering the point of view of each one.

      The objective of our study is to analyze the methods of announcing a transfer to the
      Palliative Care Unit and the perception of this announcement by the doctor and his patient
      with an incurable cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of semi-structured interviews exploring how the physician analyzes and feels the announcement of the transfer to the Palliative Care Unit and how the patient receives and disseminates this information</measure>
    <time_frame>72 hours after the transfer of the patient the to the Palliative Care Unit</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years old with solid cancer or malignant haemopathy in palliative phase
        transferred from a HUS service to the HUS UnASP
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old with solid cancer or malignant haemopathy in palliative
             phase transferred from a HUS service to the HUS UnASP and informed of this transfer by
             the originating doctor .

        HUS senior hospital doctors, supporting patients with solid cancers or malignant
        hemopathies.

        Exclusion Criteria:

          -  Patients whose clinical state does not allow for maintenance (tiredness, confusion) or
             difficult communication.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virginie LEROY, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent CALVEL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virginie LEROY, MD</last_name>
    <phone>03 88 11 65 84</phone>
    <email>virginie.leroy@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurent CALVEL, MD, PhD</last_name>
    <phone>33 3 88 11 52 66</phone>
    <email>laurent.calvel@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service : Unité de soins d'Accompagnement de soins de Support et de soins Palliatifs (UnASP)</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Virginie LEROY, MD</last_name>
      <phone>03 88 11 65 84</phone>
      <email>virginie.leroy@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Laurent CALVEL, MD, PhD</last_name>
      <phone>33 3 88 11 52 66</phone>
      <email>laurent.calvel@chru-strasbourg.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Service : Unité de soins d'Accompagnement de soins de Support et de soins Palliatifs (UnASP)</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Leroy, MD</last_name>
      <phone>03 88 11 65 84</phone>
      <email>virginie.leroy@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Laurent CALVEL, MD, PhD</last_name>
      <phone>03 88 11 52 66</phone>
      <email>laurent.calvel@chru-strasbourg.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <last_update_submitted>May 22, 2017</last_update_submitted>
  <last_update_submitted_qc>May 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>incurable pathologies</keyword>
  <keyword>palliative care</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

